Stock research

HLN Haleon plc

Healthcare • Drug Manufacturers - Specialty & Generic

$9.87
-0.24 (—%)

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness...…

5Y change

+31.60%

Range high

$11.41

Congress · 90d

0

Insiders · 90d

0

Public signal layer

Who is disclosing activity in HLN?

Latest linked filings in Indy

Congress

View all
VH Val T. Hoyle $1,001 - $15,000 SALE (FULL) Sep. 23, 2025
LM Lisa C. McClain $1,001 - $15,000 PURCHASE Jun. 24, 2025
JG Josh Gottheimer $1,001 - $15,000 SALE (PARTIAL) Apr. 9, 2025
VH Val T. Hoyle $1,001 - $15,000 PURCHASE Oct. 29, 2024

Corporate insiders

View all

No insider transactions yet.

Price

Hover to inspect price

Showing 5Y history. Source: FMP historical price full.

Prev Close
$10.11
Day High
$9.94
Day Low
$9.83
52w High
$11.28
52w Low
$8.65
Volume
9,895,365
Avg Volume
Beta
0.242

* TTM/most recent where available

Company

Ticker
HLN
Exchange
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
GB
CEO
Brian James McNamara
Employees
24535
Website
www.haleon.com

Key Metrics

Market Cap
43.5B
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available

DCF Valuation

↓ Below DCF -48.3%

Standard DCF

$19.08 as of Jul. 31, 2026

Levered DCF

$21.48 as of Jul. 31, 2026

Market Price

$9.87 vs DCF -48.3%

DCF vs Price (30D window)

Price uses last 30 days; DCF line holds latest value across the window.

DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).